名稱 | CCR2/Ga15/CHO |
型號(hào) | CBP71335 |
報(bào)價(jià) | ![]() |
特點(diǎn) | CCR2/Ga15/CHO 凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- 腫瘤細(xì)胞的熱敏感特性分析
- Western Blot標(biāo)準(zhǔn)操作流程
- 【產(chǎn)品推介】LAG-3靶點(diǎn)細(xì)胞篩選模型
- ATCC細(xì)胞株所用培養(yǎng)基有何要求?
- 【新品發(fā)布】MRD標(biāo)準(zhǔn)品_40+位點(diǎn)panel標(biāo)準(zhǔn)品
- 子宮內(nèi)膜癌精準(zhǔn)分子分型標(biāo)準(zhǔn)品,助力POLE基因檢測(cè)
- 免疫治療的下一個(gè)靶標(biāo):腫瘤相關(guān)巨噬細(xì)胞?
- 先驅(qū)還是先烈——TREM1靶點(diǎn)與藥篩細(xì)胞模型
- 分子診斷標(biāo)準(zhǔn)品,匠心出品,免費(fèi)申領(lǐng)
- 耐藥ATCC細(xì)胞株如何構(gòu)建看完就會(huì)知道
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > GPCR細(xì)胞株 > CBP71335CCR2/Ga15/CHO
![CCR2/Ga15/CHO](http://img80.chem17.com/gxhpic_a89b1029a6/fd9c5b6de14e75b1fb123653623121a27ec2e96a42f460a99ef828db9c02324f85c376ff084e9b96.jpg)
- 詳細(xì)內(nèi)容
CBP71335 | |
I. Background | |
This gene encodes two isoforms of a receptor for monocyte chemoattractant protein-1 (CCL2), a chemokine which specifically mediates monocyte chemotaxis. Monocyte chemoattractant protein-1 is involved in monocyte infiltration in inflammatory diseases such as rheumatoid arthritis as well as in the inflammatory response against tumors. The receptors encoded by this gene mediate agonist-dependent calcium mobilization and inhibition of adenylyl cyclase. | |
II. Introduction | |
Host Cell: | CHO |
Stability: | 20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | F12K+10% FBS+2 μg/ml puromycin+ 100 μg/ml Hygromycin B |
Mycoplasma Status: | Negative |
Storage: | Liquid nitrogen immediately upon delivery |
Application(s): | Functional assay for CCR2 receptor |
Transducer: | Gi |
Ⅲ. Description of Host Cell Line | |
Organism: | Hamster |
Tissue: | Ovary |
Morphology: | Epithelial |
Growth Properties: | Adherent |
Ⅳ. Representative Data |